Peptide analog type-B CCK receptor ligands
US5340802A · kind A · utility
31Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 1993 |
| Grant date | Aug 23, 1994 |
| Priority date | — |
| Expiry date | Jan 29, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide analog type-B CCK receptor ligands or pharmaceutically-acceptable salts thereof, which are useful for treating central nervous system disorders, substance abuse, gastrointestinal disorders, endocrine disorders, eating-related disorders and for the treatment of shock, respiratory and cardiocirculatory insufficiencies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.